Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy: The PEACE Study

NCT05646576 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05646576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05646576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy: The PEACE Study
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 30, 2022
Completion date
April 1, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood cancer, hematologic malignancy, leukemia, lymphoma, multiple myeloma